ReP USP - Resultado da busca

Artigo de periodico
Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases (2019)
Pileggi, Gecilmara Salviato; Mota, Licia Maria Henrique Da; Kakehasi, Adriana Maria; Souza, Alexandre Wagner De; Rocha, Aline; Melo, Ana Karla Guedes de; Fonte, Caroline Araujo M. da; Bortoletto, Cecilia; Brenol, Claiton Viegas; Borba Neto, Eduardo Ferreira
Source: Advances in rheumatology. Unidade: FM
Subjects: VACINAÇÃO, FEBRE AMARELA, INFLAMAÇÃO, IMUNOSSUPRESSÃO, TOMADA DE DECISÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PILEGGI, Gecilmara Salviato et al. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases. Advances in rheumatology, v. 59, 2019Tradução . . Disponível em: https://doi.org/10.1186/s42358-019-0056-x. Acesso em: 18 nov. 2024.
APA
Pileggi, G. S., Mota, L. M. H. D., Kakehasi, A. M., Souza, A. W. D., Rocha, A., Melo, A. K. G. de, et al. (2019). Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases. Advances in rheumatology, 59. doi:10.1186/s42358-019-0056-x
NLM
Pileggi GS, Mota LMHD, Kakehasi AM, Souza AWD, Rocha A, Melo AKG de, Fonte CAM da, Bortoletto C, Brenol CV, Borba Neto EF. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases [Internet]. Advances in rheumatology. 2019 ; 59[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s42358-019-0056-x
Vancouver
Pileggi GS, Mota LMHD, Kakehasi AM, Souza AWD, Rocha A, Melo AKG de, Fonte CAM da, Bortoletto C, Brenol CV, Borba Neto EF. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases [Internet]. Advances in rheumatology. 2019 ; 59[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s42358-019-0056-x
Artigo de periodico
Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? (2019)
Ugolini-lopes, Michelle Remiao; Gavinier, Samara S; Leon, Elaine; Viana, Vilma Trindade; Borba Neto, Eduardo Ferreira ; Bonfá, Eloísa Silva Dutra de Oliveira
Source: Clinical rheumatology. Unidade: FM
Subjects: ÁCIDO ÚRICO, NEFRITE, LÚPUS ERITEMATOSO SISTÊMICO, INSUFICIÊNCIA RENAL CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UGOLINI-LOPES, Michelle Remiao et al. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?. Clinical rheumatology, v. 38, n. 10, p. 2777-2783, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10067-019-04620-3. Acesso em: 18 nov. 2024.
APA
Ugolini-lopes, M. R., Gavinier, S. S., Leon, E., Viana, V. T., Borba Neto, E. F., & Bonfá, E. S. D. de O. (2019). Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? Clinical rheumatology, 38( 10), 2777-2783. doi:10.1007/s10067-019-04620-3
NLM
Ugolini-lopes MR, Gavinier SS, Leon E, Viana VT, Borba Neto EF, Bonfá ESD de O. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? [Internet]. Clinical rheumatology. 2019 ; 38( 10): 2777-2783.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10067-019-04620-3
Vancouver
Ugolini-lopes MR, Gavinier SS, Leon E, Viana VT, Borba Neto EF, Bonfá ESD de O. Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? [Internet]. Clinical rheumatology. 2019 ; 38( 10): 2777-2783.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s10067-019-04620-3
Artigo de periodico
Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes (2019)
Mackay, Meggan; Dall'era, Maria; Fishbein, Joanna; Kalunian, Kenneth; Lesser, Martin; Sanchez-guerrero, Jorge; Levy, Deborah M.; Silverman, Earl; Petri, Michelle; Arriens, Cristina; Borba Neto, Eduardo Ferreira; Bonfá, Eloísa Silva Dutra de Oliveira
Source: Arthritis & rheumatology. Unidade: FM
Subjects: NEFRITE, ENSAIO CLÍNICO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACKAY, Meggan et al. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes. Arthritis & rheumatology, v. 71, n. 3, p. 411-419, 2019Tradução . . Disponível em: https://doi.org/10.1002/art.40724. Acesso em: 18 nov. 2024.
APA
Mackay, M., Dall'era, M., Fishbein, J., Kalunian, K., Lesser, M., Sanchez-guerrero, J., et al. (2019). Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes. Arthritis & rheumatology, 71( 3), 411-419. doi:10.1002/art.40724
NLM
Mackay M, Dall'era M, Fishbein J, Kalunian K, Lesser M, Sanchez-guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Borba Neto EF, Bonfá ESD de O. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes [Internet]. Arthritis & rheumatology. 2019 ; 71( 3): 411-419.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/art.40724
Vancouver
Mackay M, Dall'era M, Fishbein J, Kalunian K, Lesser M, Sanchez-guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Borba Neto EF, Bonfá ESD de O. Establishing surrogate kidney end points for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes [Internet]. Arthritis & rheumatology. 2019 ; 71( 3): 411-419.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/art.40724
Artigo de periodico
Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort (2019)
Pimentel-quiroz, V. R.; Ugarte-gil, M. F.; Harvey, G. B.; Wojdyla, D.; Pons-estel, G. J.; Quintana, R.; Esposto, A.; Bonfá, Eloísa Silva Dutra de Oliveira ; Borba Neto, Eduardo Ferreira
Source: Lupus. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, DOENÇAS INFECCIOSAS, FATORES DE RISCO, ANTIMALÁRICOS, HORMÔNIOS GLICOCORTICOIDES, FÁRMACOS IMUNOSSUPRESSORES, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIMENTEL-QUIROZ, V. R. et al. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort. Lupus, v. 28, n. 9, p. 1101-1110, 2019Tradução . . Disponível em: https://doi.org/10.1177/0961203319860579. Acesso em: 18 nov. 2024.
APA
Pimentel-quiroz, V. R., Ugarte-gil, M. F., Harvey, G. B., Wojdyla, D., Pons-estel, G. J., Quintana, R., et al. (2019). Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort. Lupus, 28( 9), 1101-1110. doi:10.1177/0961203319860579
NLM
Pimentel-quiroz VR, Ugarte-gil MF, Harvey GB, Wojdyla D, Pons-estel GJ, Quintana R, Esposto A, Bonfá ESD de O, Borba Neto EF. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort [Internet]. Lupus. 2019 ; 28( 9): 1101-1110.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/0961203319860579
Vancouver
Pimentel-quiroz VR, Ugarte-gil MF, Harvey GB, Wojdyla D, Pons-estel GJ, Quintana R, Esposto A, Bonfá ESD de O, Borba Neto EF. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort [Internet]. Lupus. 2019 ; 28( 9): 1101-1110.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/0961203319860579

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies